Skip to main content
Stem Cells International logoLink to Stem Cells International
. 2017 Aug 13;2017:7946930. doi: 10.1155/2017/7946930

Corrigendum to “Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials”

Francisco Moniche 1,2,*, Paulo Henrique Rosado-de-Castro 3, Irene Escudero 1,2, Elena Zapata 1,2, Francisco Javier de la Torre Laviana 1,2, Rosalia Mendez-Otero 4, Magdalena Carmona 5, Pilar Piñero 6, Alejandro Bustamante 7, Lucía Lebrato 1, Juan Antonio Cabezas 1, Alejandro Gonzalez 6, Gabriel R de Freitas 8, Joan Montaner 2,7
PMCID: PMC5572092  PMID: 28883838

In the article titled “Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials” [1], the name of the thirteenth author was given incorrectly as Grabriel R. de Freitas. The author's name should have been written as Gabriel R. de Freitas. The revised authors' list is shown above.

References

  • 1.Moniche F., Rosado-De-Castro P. H., Escudero I., et al. Increasing dose of autologous bone marrow mononuclear cells transplantation is related to stroke outcome: results from a pooled analysis of two clinical trials. Stem Cells International. 2016;2016:8. doi: 10.1155/2016/8657173.8657173 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Stem Cells International are provided here courtesy of Wiley

RESOURCES